These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24485087)

  • 21. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.
    Bi X; Hameed M; Mirani N; Pimenta EM; Anari J; Barnes BJ
    Breast Cancer Res; 2011; 13(6):R111. PubMed ID: 22053985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 alteration in morphologically normal/benign breast tissue in patients with triple-negative high-grade breast carcinomas: breast p53 signature?
    Wang X; Stolla M; Ring BZ; Yang Q; Laughlin TS; Rothberg PG; Skinner K; Hicks DG
    Hum Pathol; 2016 Sep; 55():196-201. PubMed ID: 27246177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
    Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of miR-340 over-expression on cell-cycle-related genes in triple-negative breast cancer cells.
    Mohammadi Yeganeh S; Vasei M; Tavakoli R; Kia V; Paryan M
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 27229858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-149 Suppresses Breast Cancer Metastasis by Blocking Paracrine Interactions with Macrophages.
    Sánchez-González I; Bobien A; Molnar C; Schmid S; Strotbek M; Boerries M; Busch H; Olayioye MA
    Cancer Res; 2020 Mar; 80(6):1330-1341. PubMed ID: 31911555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel biomarker C6orf106 promotes the malignant progression of breast cancer.
    Jiang G; Zhang X; Zhang Y; Wang L; Fan C; Xu H; Miao Y; Wang E
    Tumour Biol; 2015 Sep; 36(10):7881-9. PubMed ID: 25953261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers.
    Kollara A; Kahn HJ; Marks A; Brown TJ
    Breast Cancer Res Treat; 2001 Jun; 67(3):245-53. PubMed ID: 11561770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Family history and risk of ductal carcinoma in situ and triple negative breast cancer in a Han Chinese population: a case-control study.
    Zhou W; Pan H; Liang M; Xia K; Liang X; Xue J; Cheng L; Xue J; Chen S; Liu X; Ding Q; Ling L; Wang S
    World J Surg Oncol; 2013 Oct; 11():248. PubMed ID: 24083544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer.
    Knudsen ES; McClendon AK; Franco J; Ertel A; Fortina P; Witkiewicz AK
    Cell Cycle; 2015; 14(1):109-22. PubMed ID: 25602521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer.
    Xiao M; Lou C; Xiao H; Yang Y; Cai X; Li C; Jia S; Huang Y
    Br J Surg; 2018 Jan; 105(1):75-85. PubMed ID: 29116653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-107 down-regulates SIAH1 expression in human breast cancer cells and silencing of miR-107 inhibits tumor growth in a nude mouse model of triple-negative breast cancer.
    Zhang L; Ma P; Sun LM; Han YC; Li BL; Mi XY; Wang EH; Song M
    Mol Carcinog; 2016 May; 55(5):768-77. PubMed ID: 25851994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of human tumor cell proliferation by Smurf2-induced senescence.
    Zhang H; Teng Y; Kong Y; Kowalski PE; Cohen SN
    J Cell Physiol; 2008 Jun; 215(3):613-20. PubMed ID: 18181147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program.
    Luan H; Mohapatra B; Bielecki TA; Mushtaq I; Mirza S; Jennings TA; Clubb RJ; An W; Ahmed D; El-Ansari R; Storck MD; Mishra NK; Guda C; Sheinin YM; Meza JL; Raja S; Rakha EA; Band V; Band H
    Cancer Res; 2018 May; 78(10):2524-2535. PubMed ID: 29510992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer.
    Li Q; Yao Y; Eades G; Liu Z; Zhang Y; Zhou Q
    Oncogene; 2014 May; 33(20):2589-600. PubMed ID: 23752191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E3 ubiquitin ligase CHIP attenuates cellular proliferation and invasion abilities in triple-negative breast cancer cells.
    Xu J; Wang H; Li W; Liu K; Zhang T; He Z; Guo F
    Clin Exp Med; 2020 Feb; 20(1):109-119. PubMed ID: 31845129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.